Literature DB >> 3275790

Strain variation and nuclear association of Newcastle disease virus matrix protein.

K S Faaberg1, M E Peeples.   

Abstract

Five monoclonal antibodies to the matrix (M) protein of Newcastle disease virus (NDV) Australia-Victoria (AV) strain were generated and characterized. In competitive antibody-binding assays, the antibodies fell into three discrete groups. The antigenic sites described by these antibody groups were designated M1, M2, and M3. Each antibody reacted with a panel of NDV strains in a manner unique to its group, confirming the grouping by competitive antibody binding. Only site M1 was found on all 12 of the strains tested and may be a "pan-NDV" epitope. A large portion of the M protein of strain AV was detected in the nuclei of infected cells by all five monoclonal antibodies. In addition, the antibodies only stained the nuclei of cells infected with NDV strains expressing M protein containing the corresponding antigenic site. These results confirm that the immunoreactivity in the nucleus is actually caused by the M protein and not by a cross-reacting host protein induced by viral infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3275790      PMCID: PMC250572     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  The rapid determination of binding constants for antiviral antibodies by a radioimmunoassay. An analysis of the interaction between hybridoma proteins and influenza virus.

Authors:  M E Frankel; W Gerhard
Journal:  Mol Immunol       Date:  1979-02       Impact factor: 4.407

2.  Preliminary analysis of the requirements for fusion from within and fusion from without by Newcastle disease virus.

Authors:  M A Bratt; W R Gallaher
Journal:  Proc Natl Acad Sci U S A       Date:  1969-10       Impact factor: 11.205

3.  Monoclonal antibodies against five structural components of measles virus. I. Characterization of antigenic determinants on nine strains of measles virus.

Authors:  H Sheshberadaran; S N Chen; E Norrby
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

4.  Mutation in the matrix protein of Newcastle disease virus can result in decreased fusion glycoprotein incorporation into particles and decreased infectivity.

Authors:  M E Peeples; M A Bratt
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

5.  Intracellular processing of the Newcastle disease virus fusion glycoprotein.

Authors:  T Morrison; L J Ward; A Semerjian
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

6.  Newcastle disease virus stimulates the cellular accumulation of stress (heat shock) mRNAs and proteins.

Authors:  P L Collins; L E Hightower
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

7.  Isolation and purification of the envelope proteins of Newcastle disease virus.

Authors:  A Scheid; P W Choppin
Journal:  J Virol       Date:  1973-02       Impact factor: 5.103

8.  Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein.

Authors:  R M Iorio; M A Bratt
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

9.  Antigenic characterization of influenza A virus matrix protein with monoclonal antibodies.

Authors:  K L van Wyke; J W Yewdell; L J Reck; B R Murphy
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

10.  Hemolytic interaction of Newcastle disease virus and chicken erythrocytes. II. Determining factors.

Authors:  L A Clavell; M A Bratt
Journal:  Appl Microbiol       Date:  1972-03
View more
  13 in total

1.  Requirements for the assembly and release of Newcastle disease virus-like particles.

Authors:  Homer D Pantua; Lori W McGinnes; Mark E Peeples; Trudy G Morrison
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

2.  Fusion and matrix protein gene sequence analysis of paramyxoviruses of type 1(PMV-1) isolated from pigeons in Slovenia.

Authors:  Darja Barlic-Maganja; Uros Krapez; Sara Mankoc; Ivan Toplak; Olga Zorman Rojs
Journal:  Virus Genes       Date:  2005-12       Impact factor: 2.332

3.  Nuclear localization of Semliki Forest virus-specific nonstructural protein nsP2.

Authors:  J Peränen; M Rikkonen; P Liljeström; L Kääriäinen
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

4.  Integrity of membrane lipid rafts is necessary for the ordered assembly and release of infectious Newcastle disease virus particles.

Authors:  Jason P Laliberte; Lori W McGinnes; Mark E Peeples; Trudy G Morrison
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

5.  Nuclear entry and nucleolar localization of the Newcastle disease virus (NDV) matrix protein occur early in infection and do not require other NDV proteins.

Authors:  M E Peeples; C Wang; K C Gupta; N Coleman
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

6.  Nuclear transport of plant potyviral proteins.

Authors:  M A Restrepo; D D Freed; J C Carrington
Journal:  Plant Cell       Date:  1990-10       Impact factor: 11.277

7.  Restricted expression of viral surface proteins in canine distemper encephalitis.

Authors:  S Alldinger; W Baumgärtner; C Orvell
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

8.  Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding.

Authors:  Yao E Wang; Arnold Park; Michael Lake; Mickey Pentecost; Betsabe Torres; Tatyana E Yun; Mike C Wolf; Michael R Holbrook; Alexander N Freiberg; Benhur Lee
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

9.  Analysis of matrix protein gene nucleotide sequence diversity among Newcastle disease virus isolates demonstrates that recent disease outbreaks are caused by viruses of psittacine origin.

Authors:  B S Seal
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

10.  Incorporation of functional HN-F glycoprotein-containing complexes into newcastle disease virus is dependent on cholesterol and membrane lipid raft integrity.

Authors:  Jason P Laliberte; Lori W McGinnes; Trudy G Morrison
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.